Healthcare & Life Sciences
Engrail
United Stateswww.engrail.com/
Engrail is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 3 tracked investors.
activeseries-b
series-b
Stage
2019
Founded
3
Investors
About Engrail
Engrail is a company founded in 2019 headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Engrail is a clinical-stage pharmaceutical company developing precision-targeted therapies for neurological and neuropsychiatric disorders.
Explore Engrail's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.